Risk Factors for Neuroendocrine Neoplasms

Recruiting Observational Study
Neuroendocrine Neoplasm of Lung Neuroendocrine Neoplasm of Gastrointestinal Tract (Disorder)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
14,250 (estimated)
Sponsor
Bavarian Cancer Registry · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Recent studies show an increase in neuroendocrine neoplasms, especially for the digestive tract. Previous studies suggest various risk factors that were observed for various tumor sites, e.g. a family history of cancer, tobacco and alcohol consumption as well as metabolic disorders including diabetes and obesity. A risk factor that has been little studied to date is depressive disorders, which cou…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Persons with a statutory health insurance (about 85% of the population) and at least one outpatient physician contact in Bavaria between 2021 and 2023 * Residence in Bavaria Exclusion Criteria: * None
Contacts

Sven Voigtländer

+49-(0)9131-6808

sven.voigtlaender@lgl.bayern.de

CONTACT

Jacqueline Müller-Nordhorn

+49-(0)9131-6808

jacqueline.mueller-nordhorn@lgl.bayern.de

CONTACT